Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
March 16, 2023 at 07:35 am EDT
Monte Rosa Therapeutics, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 30.78 million compared to USD 23.44 million a year ago. Basic loss per share from continuing operations was USD 0.63 compared to USD 0.5 a year ago.
For the full year, net loss was USD 108.5 million compared to USD 73.96 million a year ago. Basic loss per share from continuing operations was USD 2.3 compared to USD 2.96 a year ago.